Bristol Myers Squibb picks Houston for $2.3 billion campus

Zoom in: The campus will be built at Generation Park, a commercial development in northeast Houston.

• The project will also create roughly 2,000 construction and other indirect jobs between 2027 and 2030 as the center is built.

State of play: The New Jersey-based drugmaker selected Houston for a new manufacturing campus designed to produce several types of medicines, like small molecules, biologics and antibody-drug conjugates.

• The campus will be able to adjust its manufacturing capacity as the company's drug pipeline changes.

Zoom out: The Houston project is part of Bristol Myers Squibb's previously announced plan to invest $40 billion in U.S. research and development, technology and manufacturing over five years.

What they're saying: CEO Christopher Boerner said Houston and Texas offer the "talent, infrastructure, and partnership" the company needs to expand its domestic manufacturing operations.

• "This $2.3 billion investment by Bristol Myers Squibb in the dynamic biotech ecosystem in Houston is a testament to the depth of our skilled workforce and the pipeline of talent coming through our nation-leading technical colleges and research universities," said Gov. Greg Abbott in the announcement.